Cargando…
非小细胞肺癌EGFR-TKIs耐药——小细胞肺癌转化的研究进展
The use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in the treatment of sensitive EGFR mutation in non-small cell lung cancer (NSCLC) has been proved significant curative effect. However, the acquisition of the drug resistance to EGFR-TKIs is almost inevitable, and com...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972996/ https://www.ncbi.nlm.nih.gov/pubmed/29061221 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.10.10 |